Ann: Update on BLA for Graft Versus Host Disease, page-737

For someone who claims to work in the medical industry, you seem to lack an understanding of how big pharma work / pounce on situations like this ? They are greedy, opportunistic and seek to expand their footprint of drugs and treatments when opportunistic scenarios present themselves....

..... you say it wont happen and I believe it will and I have kept that theory consistent from prior to the FDA decision where I stated I thought we would be taken over regardless of the FDA decision (negative or positive)


As I said in my post, if there was a big pharma interested they won't want any momentum from a (now I believe) a heavily discounted partnership to surface .... a product could now be licensed out cheap to keep afloat and/or any positivity from either the Type A meeting or the CHF FDA meeting .... they wont want that IMO and will act now ?


.... I guess we will see if Mesoblast exists in 6 - 12 months ... enjoy your weekend.